Foot gel prescribed to diabetics can lead to death

Gel foot of Johnson & Johnson, used by diabetics, increases the risk of cancer and deaths, said the American officials from the Ministry of Health. Office of the FDA Food and Drug Administration (FDA) announced that, following consideration of the gel, called Regranex, found an increase in cancer deaths in patients assigned to the gel were used. Regranex - gel is administered in patients with diabetes, heal the wounds on his legs. Barbara Montresor, one of the developers of the gel, said that the gel is safe when used properly. Patients with diabetes are prone to injury. The wounds are very difficult to cure, especially in the legs, due to the high sugar in the blood. Anxiety-related deaths from 1998 to 2003 occurred in diabetic patients after using the gel. None of the types of cancers has not then identified in the patient. However, the previous study was conducted in 2001, showed that in patients who Regranex, more cases of cancer than in those who did not use to use this gel. Further studies are needed to determine precisely. The degree of risk of the drug, according to representatives of the FDA